Femme et Homme
- | Pays :
- Netherlands
- Germany
- France
- | Organes : -
- | Spécialités : -
Extrait
Part 1: The primary purpose is to determine the recommended dose of E7070 in combination with capecitabine by dose adjustment. Part 2: The primary purpose is to determine the safety and efficacy of the combination in patients with metastatic CRC resistant to 5-fluorouracil and irinotecan.
Critère d'inclusion
- Colorectal cancer (CRC)